Cargando…

Molecular Mechanism of Pathogenesis and Treatment Strategies for AL Amyloidosis

In amyloid light-chain (AL) amyloidosis, small B-cell clones (mostly plasma cell clones) present in the bone marrow proliferate and secrete unstable monoclonal free light chains (FLCs), which form amyloid fibrils that deposit in the interstitial tissue, resulting in organ injury and dysfunction. AL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikura, Hidehiko, Endo, Jin, Kitakata, Hiroki, Moriyama, Hidenori, Sano, Motoaki, Fukuda, Keiichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181426/ https://www.ncbi.nlm.nih.gov/pubmed/35683015 http://dx.doi.org/10.3390/ijms23116336

Ejemplares similares

Step‐by‐step typing for the accurate diagnosis of concurrent light chain and transthyretin cardiac amyloidosis
por: Moriyama, Hidenori, et al.
Publicado: (2022)

Early Diagnosis of Amyloid Cardiomyopathy: Potential and Need Before the Onset of Decompensated Heart Failure
por: Moriyama, Hidenori, et al.
Publicado: (2021)

Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis
por: Kitakata, Hiroki, et al.
Publicado: (2022)

Qualitative and Quantitative Effects of Fatty Acids Involved in Heart Diseases
por: Moriyama, Hidenori, et al.
Publicado: (2022)

MerTK Expression and ERK Activation Are Essential for the Functional Maturation of Osteopontin‐Producing Reparative Macrophages After Myocardial Infarction
por: Shirakawa, Kohsuke, et al.
Publicado: (2020)

(Pro)renin receptor accelerates development of sarcopenia via activation of Wnt/YAP signaling axis
por: Yoshida, Naohiro, et al.
Publicado: (2019)

Patient Perspectives in the Era of Remote Medical Visits During the Coronavirus Disease (COVID-19) Pandemic　― Insights From Outpatient Care of Cardiovascular Disease ―
por: Kitakata, Hiroki, et al.
Publicado: (2021)

Omega-3 fatty acid epoxides produced by PAF-AH2 in mast cells regulate pulmonary vascular remodeling
por: Moriyama, Hidenori, et al.
Publicado: (2022)

Pharmacokinetics of hydrogen after ingesting a hydrogen-rich solution: A study in pigs
por: Ichihara, Genki, et al.
Publicado: (2021)

Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms and echocardiograms
por: Goto, Shinichi, et al.
Publicado: (2021)

Decrease in membrane phospholipids unsaturation correlates with myocardial diastolic dysfunction
por: Yamamoto, Tsunehisa, et al.
Publicado: (2018)

H(2) Inhibits the Formation of Neutrophil Extracellular Traps
por: Shirakawa, Kohsuke, et al.
Publicado: (2022)

18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload–induced maladaptive cardiac remodeling
por: Endo, Jin, et al.
Publicado: (2014)

AL AMYLOIDOSIS: MECHANISMS OF DISEASE AND BIOMARKERS
por: Palladini, Giovanni, et al.
Publicado: (2022)

Feasibility of the deep learning method for estimating the ventilatory threshold with electrocardiography data
por: Miura, Kotaro, et al.
Publicado: (2020)

AL Amyloidosis
por: Desport, Estelle, et al.
Publicado: (2012)

Molecular Mechanisms of Cardiac Amyloidosis
por: Saito, Yukihiro, et al.
Publicado: (2021)

Real-time analysis of heart rate variability during aerobic exercise in patients with cardiovascular disease
por: Ikura, Hidehiko, et al.
Publicado: (2022)

Negative legacy of obesity
por: Shirakawa, Kohsuke, et al.
Publicado: (2017)

Association of Skin with the Pathogenesis and Treatment of Neurodegenerative Amyloidosis
por: Clos, Audra L., et al.
Publicado: (2012)

Biomarkers in AL Amyloidosis
por: Fotiou, Despina, et al.
Publicado: (2021)

Diagnosis and Treatment of AL and ATTR Amyloidosis
por: Faiman, Beth, et al.
Publicado: (2021)

Real-Time Estimation of Anaerobic Threshold during Exercise Using Electrocardiogram in Heart Failure Patients
por: Ryuzaki, Toshinobu, et al.
Publicado: (2023)

Low-Grade Inflammation in the Pathogenesis of Osteoarthritis: Cellular and Molecular Mechanisms and Strategies for Future Therapeutic Intervention
por: Terkawi, M Alaa, et al.
Publicado: (2022)

Amyloidosis-inducing activity of blood cells in mouse AApoAII amyloidosis
por: Ding, Xin, et al.
Publicado: (2017)

Recent Insights into the Pathogenesis of Type AA Amyloidosis
por: van der Hilst, J. C. H.
Publicado: (2011)

Pathophysiological Involvement of Mast Cells and the Lipid Mediators in Pulmonary Vascular Remodeling
por: Moriyama, Hidenori, et al.
Publicado: (2023)

Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis
por: Palladini, Giovanni, et al.
Publicado: (2021)

Therapeutic impact of dietary vitamin D supplementation for preventing right ventricular remodeling and improving survival in pulmonary hypertension
por: Tanaka, Hiroaki, et al.
Publicado: (2017)

Cardiac amyloidosis: evolving pathogenesis, multimodal diagnostics, and principles of treatment
por: Medarametla, Gnana Deepthi, et al.
Publicado: (2023)

Patient confidence regarding secondary lifestyle modification and knowledge of ‘heart attack’ symptoms following percutaneous revascularisation in Japan: a cross-sectional study
por: Kitakata, Hiroki, et al.
Publicado: (2018)

Unilateral conjunctival AL kappa amyloidosis with trace evidence of systemic amyloidosis
por: Abdallah, Al-Ola, et al.
Publicado: (2012)

Laminar flow ventilation system to prevent airborne infection during exercise in the COVID-19 crisis: A single-center observational study
por: Katsumata, Yoshinori, et al.
Publicado: (2021)

Tocilizumab preserves renal function in rheumatoid arthritis with AA amyloidosis and end-stage kidney disease: Two case reports
por: Fukuda, Makoto, et al.
Publicado: (2021)

AL amyloidosis: advances in diagnosis and management
por: Koh, Youngil
Publicado: (2020)

AL Amyloidosis Presenting With Crescentic Glomerulonephritis
por: Wang, Ann A., et al.
Publicado: (2021)

Current Updates on the Management of AL Amyloidosis
por: Elsayed, Marwa, et al.
Publicado: (2021)

Role of Daratumumab in Cardiac AL Amyloidosis
por: Gertz, Morie A.
Publicado: (2022)

NEW-ONSET CARDIAC AMYLOIDOSIS WHILE IN REMISSION FROM SYSTEMIC AL AMYLOIDOSIS
por: Idowu, Abiodun, et al.
Publicado: (2023)

Prognostic values of novel biomarkers in patients with AL amyloidosis
por: Kim, Darae, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vrh5fptdpmactu9p7pauteir8c